Electrophysiological characteristics and outcomes of radiofrequency catheter ablation for paroxysmal supraventricular tachycardia at Hanoi Medical University Hospital in 2025
Main Article Content
Abstract
Paroxysmal supraventricular tachycardia (PSVT) is a common cardiac arrhythmia that often causes significant symptoms affecting quality of life and may lead to cardiovascular complications if prolonged. Among the underlying mechanisms, atrioventricular nodal reentrant tachycardia (AVNRT) and atrioventricular reentrant tachycardia (AVRT) are the most frequent. A total of 123 patients diagnosed with supraventricular tachycardia and indicated for radiofrequency catheter ablation according to the 2019 European Society of Cardiology guidelines were enrolled at Hanoi Medical University Hospital from January 2025 to December 2025. A short-term longitudinal descriptive study design was conducted. The mean age of the study population was 50.67 ± 16.11 years, with female predominance and most patients having no concomitant cardiovascular diseases. AVNRT was more common in older patients, whereas AVRT predominated in younger individuals; atrial tachycardia showed a relatively uniform age distribution. Left-sided accessory pathways were more frequently observed, and the most common origin of atrial tachycardia was near the coronary sinus ostium. The procedural success rate was 97.6%. Complications were mainly minor, including vascular access hematoma and vagal reactions, with no major complications reported.
Article Details
Keywords
supraventricular tachycardia, AVRT, AVNRT, atrial tachycardia
References
2. Brugada J, Katritsis DG, Arbelo E, et al. 2019 ESC Guidelines for the management of patients with supraventricular tachycardiaThe Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC). Eur Heart J. 2020;41(5):655-720. doi:10.1093/eurheartj/ehz467
3. Page RL, Joglar JA, Caldwell MA, et al. 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2016;133(14):e471-505. doi:10.1161/CIR.0000000000000310
4. Tan ESJ, Chan SP, Seow SC, et al. Outcomes of supraventricular tachycardia ablation: Results from the Singapore ablation and cardiac devices registry. Pacing Clin Electrophysiol. 2022;45(1):50-58. doi:10.1111/pace.14410
5. Thái NH, Hùng PN, Diễm NT, Minh NHQ, Lộc LM. Hiệu quả điều trị nhịp nhanh kịch phát trên thất và rối loạn nhịp thất bằng sóng tần số radio tại Bệnh viện Hoàn Mỹ Cửu Long. VJCTS. 2025;52:127-133. doi:10.47972/vjcts.v52i.1501
6. Ávila P, Calvo D, Tamargo M, et al. Association of age with clinical features and ablation outcomes of paroxysmal supraventricular tachycardias. Heart. 2022;108(14):1107-1113. doi:10.1136/heartjnl-2021-319685
7. Jackman WM, Wang XZ, Friday KJ, et al. Catheter ablation of accessory atrioventricular pathways (Wolff-Parkinson-White syndrome) by radiofrequency current. N Engl J Med. 1991;324(23):1605-1611. doi:10.1056/NEJM199106063242301
8. Weng KP, Wolff GS, Young ML. Multiple accessory pathways in pediatric patients with Wolff-Parkinson-White syndrome. Am J Cardiol. 2003;91(10):1178-1183. doi:10.1016/s0002-9149(03)00263-7
9. Katritsis DG, Boriani G, Cosio FG, et al. European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardiaca y Electrofisiologia (SOLAECE). Eur Heart J. 2018;39(16):1442-1445. doi:10.1093/eurheartj/ehw455
10. Liu XY, Jacobsen PK, Pehrson S, Chen X. Catheter Ablation of Focal Atrial Tachycardia Using Remote Magnetic Navigation. J Invasive Cardiol. 2018;30(4):126-132.
11. Kistler PM, Roberts-Thomson KC, Haqqani HM, et al. P-wave morphology in focal atrial tachycardia: development of an algorithm to predict the anatomic site of origin. J Am Coll Cardiol. 2006;48(5):1010-1017. doi:10.1016/j.jacc.2006.03.058